[
    [
        {
            "time": "",
            "original_text": "【浙商|孙建】药明康德：CDMO加速验证，2021年仍可期",
            "features": {
                "keywords": [
                    "药明康德",
                    "CDMO",
                    "加速验证",
                    "2021年"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【浙商|孙建】药明康德：CDMO加速验证，2021年仍可期",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "近八成个股上涨，各类\"茅\"跌3.4万亿，后市操作指南来了…",
            "features": {
                "keywords": [
                    "个股上涨",
                    "茅指数",
                    "下跌",
                    "后市操作"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "近八成个股上涨，各类\"茅\"跌3.4万亿，后市操作指南来了…",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "基因测序一周风云榜：药明康德市值大缩水，金域医学两股东三个月减持477万股 减持股份",
            "features": {
                "keywords": [
                    "基因测序",
                    "药明康德",
                    "市值缩水",
                    "金域医学",
                    "减持"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "基因测序一周风云榜：药明康德市值大缩水，金域医学两股东三个月减持477万股 减持股份",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "药明康德(603259)2020年业绩快报点评：CDMO加速验证 2021年仍可期",
            "features": {
                "keywords": [
                    "药明康德",
                    "2020年业绩",
                    "CDMO",
                    "加速验证",
                    "2021年"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德(603259)2020年业绩快报点评：CDMO加速验证 2021年仍可期",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]